Edaravone API Market, Global Outlook and Forecast 2023-2030
Edaravone is a free radical scavenger approved in May, 2017 for the treatment of amyotrophic lateral scleorosis (ALS). Clinical studies showed that the treatment attenuated deterioration of the disease when compared to placebo. It has been previously investigated for the treatment of ischemic stroke, reperfusion Injury, and myocardial Infarction as it possesses antioxidant and anti-apoptotic properties. Being a low molecular weight molecule with good water and lipid-soluble properies, it is therapeutically advantageous in crossing the blood-brain barrier to mediate nootropic and neuroprotective effects. Oral formulation of edaravone is currently under development.
This report aims to provide a comprehensive presentation of the global market for Edaravone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone API. This report contains market size and forecasts of Edaravone API in global, including the following market information:
Global Edaravone API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Edaravone API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Edaravone API companies in 2022 (%)
The global Edaravone API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Edaravone API include Dr. Reddy?s Laboratories Ltd., ChemWerth Inc, Medichem S.A, Solara Active Pharma Sciences, Neuland Laboratories and Jiangsu Haici Bio-Pharmaceutical Co., Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Edaravone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Edaravone API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Edaravone API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Edaravone API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Edaravone API Market Segment Percentages, by Application, 2022 (%)
Edaravone Injection
Others
Global Edaravone API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Edaravone API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Edaravone API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Edaravone API revenues share in global market, 2022 (%)
Key companies Edaravone API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Edaravone API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy?s Laboratories Ltd.
ChemWerth Inc
Medichem S.A
Solara Active Pharma Sciences
Neuland Laboratories
Jiangsu Haici Bio-Pharmaceutical Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Edaravone API, market overview.
Chapter 2: Global Edaravone API market size in revenue and volume.
Chapter 3: Detailed analysis of Edaravone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Edaravone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Edaravone API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
